Affective Control Training (AffeCT) reduces negative affect in depressed individuals.

Affective control Cognitive control Depression Emotion Emotional Stroop Negative affect

Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
15 09 2022
Historique:
received: 24 08 2021
revised: 09 06 2022
accepted: 16 06 2022
pubmed: 7 7 2022
medline: 20 7 2022
entrez: 6 7 2022
Statut: ppublish

Résumé

Depression is the leading cause of disability worldwide, with prevalence rates rising. Despite the scale of the problem, available pharmacological and psychological interventions only have limited efficacy. The National Institute of Health's Science of Behaviour Change framework proposes to address this issue by capitalising on insights from basic science to identify mechanisms that can be targeted by novel interventions. The current study evaluated the potential of a computerized programme aimed at improving affective control, a mechanistic target involved in both risk and maintenance of depression. In a first phase the cognitive profiles of 48 depressed individuals (mean age: 39 years, 75 % female) were compared to cognitive functioning in 16 never-depressed individuals (mean age: 31 years, 56 % female). The sole index of functioning that differed between diagnostic groups was reaction time across negative and positively valanced trials on an affective Stroop task (d = 0.58). This index was then used to evaluate an affective control training (AffeCT) against a placebo training. Results showed no significant changes on tasks that showed no differences with never-depressed individuals in Phase I. However, compared to placebo training, AffeCT led to significantly greater improvement in the target index, affective Stroop performance (d = 1.17). Importantly, AffeCT led to greater reductions in negative affect as measured by the Positive Affect and Negative Affect Schedule compared to the placebo training (d = 0.98). This proof-of-concept study shows promising benefits of AffeCT on depressed individuals' affect, but not depressive symptoms. It further supports the utility of the Science of Behaviour Change framework, highlighting the need for determining meaningful assays of target mechanisms when evaluating novel interventions.

Identifiants

pubmed: 35792299
pii: S0165-0327(22)00676-0
doi: 10.1016/j.jad.2022.06.016
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

167-176

Subventions

Organisme : Medical Research Council
ID : MC_UU_00030/5
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R61 MH121560
Pays : United States
Organisme : Wellcome Trust
ID : 209127/Z/17/Z
Pays : United Kingdom

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Susanne Schweizer (S)

University of Cambridge, Department of Psychology, Cambridge, UK; University of New South Wales, School of Psychology, Sydney, Australia. Electronic address: ss816@cam.ac.uk.

Tibor Auer (T)

University of Surrey, School of Psychology, Guildford, UK.

Caitlin Hitchcock (C)

University of Cambridge, Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK; University of Melbourne, Melbourne School of Psychological Sciences, Melbourne, Australia.

Leonie Lee-Carbon (L)

University of Cambridge, Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK.

Evangeline Rodrigues (E)

University of Cambridge, Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK.

Tim Dalgleish (T)

University of Cambridge, Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH